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To support diagnostic and preventive decision making, we ana-
lyzed incidence of Lyme disease in Maryland on the zip code
level. Areas of high incidence were identified on the Upper
Eastern Shore of the Chesapeake Bay and in counties north
and east of Baltimore City. These latter foci, especially, are not
visible when mapping Lyme disease on the county level.
yme disease (LD) is a multisystem infectious and inflam-
matory disease resulting from infection with the spiro-
chete Borrelia burgdorferi. It is by far the most commonly
reported vector-borne disease in the United States and is trans-
mitted by the bite of infected Ixodes scapularis ticks (1). In the
United States, areas at high risk for the disease focally occur in
temperate wooded habitats sustaining B. burgdorferi’s small
mammalian hosts, predominantly the white-footed mouse (Per-
omyscus leucopus), as well as the preferred mating place for
adult ticks, on the white-tailed deer (Odocoilus virginianus) (2).
We have reported the incidence of LD for Maryland by
county (3). Glass and colleagues developed a detailed LD risk
map of Baltimore County by using environmental risk factors
within a geographic information system (GIS) (4). The objec-
tive of our report is to show areas of high incidence of LD on a
level more detailed than the standard reporting by county. The
next most detailed geographic boundary system for which
population data are available is the zip code level. It provides
intermediate detail between counties and census blocks. The
zip code also allows incidence calculations based on census
population figures and, by relying on postal address, uses a
feature of geographic reference very commonly available to
state health departments n Maryland and elsewhere. We
believe this level of detail in mapping the focal distribution of
LD will improve decision-making regarding diagnoses, per-
sonal and community interventions, and cost-effective use of
vaccine. 
The Study
Included in our report were all cases meeting the national
surveillance case definition for LD (5) reported to the Mary-
land Department of Health and Mental Hygiene (DHMH) with
a known date of onset from 1993 through 1998 and a residen-
tial zip code mailing address.
All cases were referenced to zip code of residence. Demo-
graphic data from the 1990 census are publicly available for
the zip code level (6). In 1990, population figures for Mary-
land zip codes ranged from 39 to 56,594 (median 3,042). To
obtain larger units of population for more stable estimates of
incidence, small zip codes were combined with the next small-
est neighboring zip codes until the aggregated zip code area
(AZCA) reached the size of >600 residents or more. Annual
average incidence per zip code or AZCA was calculated as the
average number of cases from 1993 through 1998 per 100,000
population. One hundred six small-population zip codes were
combined with others to give 50 AZCAs, ranging in size from
616 to 51,683 (median 1,791). Most AZCAs were located in
western Maryland (non disease-endemic area) and the Eastern
Shore (highly endemic area). The 1990 census did not contain
population data for 15 zip codes, so their incidence could not
be calculated.
Analysis and data management were performed with Epi-
Info version 6.04 and Microsoft EXCEL version 7.0; maps
were created with ArcInfo (ESRI, Redlands, CA).
A total of 2,399 cases reported to the DHMH with a known
date of onset from 1993 through 1998 met the national surveil-
lance case definition for LD. This report includes the 2,371
(99%) patients for whom mailing addresses were available.
Cases were reported from 344 (80%) of 431 zip codes. Only 6
of the 33 zip codes from western Maryland (Garrett,
Allegheny, Washington, and Frederick Counties) reported
cases of LD during the study period.
Two areas of high incidence are evident: the Upper Eastern
Shore (Cecil, Kent, Queen Anne’s, Caroline, and Talbot Coun-
ties), and focal areas north and east of Baltimore City in Balti-
more and Harford Counties (Figure). This latter area is part of
an arc of increased incidence, from Montgomery County in the
south, extending northeast through Howard, southeastern Car-
roll, Baltimore, and Harford Counties into Cecil County. This
arc parallels the “fall line,” the topographic boundary where
the Coastal Plains meet the Piedmont and land elevations
begin to rise towards the Appalachian Mountains.
In Baltimore County, the area with the highest incidence
extends along the vegetational corridors bordering the Gun-
powder Falls river system and associated reservoirs. In Har-
ford County, a similar but less confined linear pattern follows
the runs of Broad Creek and Deer Creek. On the Upper East-
ern Shore high incidence is more uniformly observed, without
any clear topographic pattern. The scattered zip codes on the
Lower Eastern and Lower Western Shores that show higher
incidence than surrounding areas are all AZCAs with rather
small populations and resultant wide confidence intervals for
their incidence estimates.
Conclusions
The detailed mapping of LD in Maryland identifies an area
of high LD incidence north of Baltimore City that is not be
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apparent when mapping on the county level (3). When ana-
lyzed by counties, focal high incidence along Gunpowder
River and Deer Creek is diluted by adjacent areas of lower
incidence, especially the northern inner suburbs of Baltimore
City with their comparatively urban environment. These foci
are aligned along the larger rivers and creeks in an environ-
ment that is ideal for transmission of the disease. Within the
floodplain and on valley slopes of the rivers descending from
the Piedmont lie corridors of forest and brush, cutting through
rural and suburban areas. Farms, estates, individual houses,
and housing developments lie within and adjoin these ideal
tick habitats. Local outdoor recreation is widespread. The
extent of the high-risk area in Baltimore County is congruent
with Glass’s detailed GIS results (4).
In contrast, Maryland’s Upper Eastern Shore, a rural area
situated entirely in the Coastal Plain with an ideal tick habitat,
has uniformly high LD incidence. However, southern Mary-
land (north of the Potomac River) and the Lower Eastern
Shore have a low incidence of LD. This correlates with limited
ecologic data showing much lower B. burgdorferi infection
rates in I. scapularis in southern Maryland and the Lower
Eastern Shore than in the Upper Eastern Shore (7,8). Almost
no LD was reported in western Maryland from Frederick
County westward; this virtual absence is consistent with the
low prevalence of I. scapularis and low B. burgdorferi infec-
tion rates in this tick species, despite an abundance of rodents
and deer in this mountainous region (7,8).
Spot-mapping of LD cases is useful for tracking LD trans-
mission but can be misleading about incidence because popu-
lation density is not taken into consideration. On a spot map,
based on the absolute number of cases, a sparsely populated
area with high LD incidence may
be indistinguishable from another
area with high population density
and low incidence. Incidence fig-
ures for counties containing both
highly urban and highly rural
areas are likely not representative
of the rural areas because of the
concentration of population in the
urban part. Health-care providers
must appreciate the fact that, for
instance, more cases of LD are
reported from Baltimore County
(population ~1 million) than from
Cecil County (population
20,000), even though the county-
level incidence of LD is much
higher in Cecil County.
Characterization of LD inci-
dence on the zip code level is fea-
sible using data collected
routinely by local health depart-
ments. Zip code level data pro-
vide more detailed information
than county level data and require less data and effort than GIS
risk modeling based on vegetation parameters and tick distri-
bution (4, 9-11). Although LD risk-mapping based on preva-
lence of infection in ticks would be the most accurate method
(12), tick data are often unavailable, out-of-date, costly, and
difficult to collect. A potential limitation of our report is that
incidence has been referenced to residential addresses,
whereas patients may have been infected elsewhere. However,
residence in an LD-endemic area is a well-recognized risk fac-
tor for infection (12). Many studies have reported that patients
with LD usually believe they were infected at their homes,
places of work, or some nearby recreational site (13-17). A
calculated entomologic risk index showed a strong positive
relation with the geographic LD case rate in Rhode Island
(18). Most (58%) of our study participants who remembered a
tick bite believed it occurred at or near their place of residence;
an additional 21% were bitten during recreation and 9% at
work. Patients in high incidence areas were more likely to
report a tick bite near their home than were those living in
more urban areas or in western Maryland. Referencing LD
cases to their residence is a useful proxy for the actual place
patients acquired a tick bite.
Knowledge of focal LD risk distilled from mapping on the
zip code level is of value to the general public. It can focus
efforts to reduce tick exposure and increase motivation to use
appropriate preventive measures when tick exposure is
unavoidable. Such mapping can also aid health-care providers
in assessing the likelihood of a particular patient’s having LD
(19).
Meltzer et al. estimated how much the cost-effectiveness
of LD vaccination depends on individual risk (20). Mapping
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LD incidence in detail complements the Centers for Disease
Control and Prevention’s (CDC’s) recommendation that the
LD vaccine be administered based on residential, occupa-
tional, and recreational risk assessment (21). The CDC report
recognizes the need to “develop maps of geographic distribu-
tion of LD with improved accuracy and predictive power”
beyond the county-based national LD risk map. This level of
detail would aid the “Healthy People 2010” goal of LD pre-
vention through targeted vaccination (22).
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